AZ Daiichi UK deal

AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports

AstraZeneca and Daiichi Sankyo are nearing a pricing agreement with UK regulators for their breast cancer drug Enhertu following a previous coverage denial. Talks aim to secure reimbursement access wh